Aims of the study are:(1) to test the short-term efficacy of MAS in the treatment of children with SDB; and (2) to assess the effect of MAS treatment on quality of life, behavior, growth hormone levels, and nocturnal enuresis in SDB children. The gene discussed is GH1; the disease is sleep apnea syndrome.